China’s Sinovac secures $500 million in funding for Covid-19 vaccine development | World News - Hindustan Times
close_game
close_game

China’s Sinovac secures $500 million in funding for Covid-19 vaccine development

Shanghai | ByReuters| Posted by Susmita Pakrasi
Dec 07, 2020 06:23 AM IST

In a statement on its website, the company said it expects to be able to manufacture 300 million vaccine doses annually, and that it aims to complete construction of a second production facility by the end of 2020 to increase annual Covid-19 vaccine production capacity to 600 million doses.

China’s Sinovac Biotech said on Monday that it had secured approximately $500 million in funding for Covid-19 vaccine development.

Sinovac said the investor is Sino Biopharmaceutical Ltd.(Reuters)
Sinovac said the investor is Sino Biopharmaceutical Ltd.(Reuters)

In a statement on its website, the company said it expects to be able to manufacture 300 million vaccine doses annually, and that it aims to complete construction of a second production facility by the end of 2020 to increase annual Covid-19 vaccine production capacity to 600 million doses.

Hindustan Times - your fastest source for breaking news! Read now.

Sinovac said the investor is Sino Biopharmaceutical Ltd.

Unlock a world of Benefits with HT! From insightful newsletters to real-time news alerts and a personalized news feed – it's all here, just a click away! - Login Now!

Get Latest World News along with Latest News from India at Hindustan Times.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Friday, March 29, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On